Novavax Inc
Novavax Inc (NVAX) Wheel Strategy
NVAX wheel strategy scan found 24 cash-secured put setups on the previous trading day. Probability of expiring worthless is above 50%. Annualized returns reach up to 235.9%.
Read more
Running a NVAX wheel strategy lets you generate consistent premium income on Novavax Inc while setting your own entry and exit prices on the underlying. Novavax Inc's wheel combines cash-secured puts and covered calls into a repeatable cycle: sell puts at strikes where you'd be happy to own NVAX, and if assigned, sell calls at strikes where you'd be happy to sell. Use our scanner to find the best NVAX wheel strategy setups in real time.
The wheel works best on liquid, high-quality names with stable fundamentals and active options markets — exactly the profile many large-cap leaders fit. The mechanics are simple: sell a cash-secured put on NVAX, collect premium, and either keep the premium if it expires worthless or take assignment at a discount to current price. Once assigned, sell covered calls against the shares to keep collecting premium until they're called away. Choosing the right strikes, expirations, and IV environment is what separates a profitable NVAX wheel from a losing one.
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; NanoFlu, a nanoparticle seasonal quadrivalent influenza vaccine candidate that is in Phase 3 clinical trial; and ResVax, a respiratory syncytial virus (RSV) fusion (F) protein nanoparticle vaccine candidate. It is also developing RSV F vaccine that is in Phase II clinical trial for older adults (60 years and older), as well as that is in Phase I clinical trial for pediatrics.
It has a collaboration agreement with Takeda Pharmaceutical Company Limited for the development, manufacturing, and commercialization of NVX-CoV2373, a COVID-19 vaccine candidate. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.
The difference between a wheel that compounds and one that bleeds comes down to strike selection, IV timing, and discipline on assignment. Our scanner handles the heavy lifting: it ranks every leg of the NVAX wheel strategy by delta, premium yield, IV rank, and days to expiration, so you can deploy capital where the math works. Build your NVAX wheel strategy on data, not gut feel — and let the options wheel do what it does best: pay you to wait.
| Oct 2, 2026 | 10.00 | $0.25 | $0.91 | -0.43 | 14 | 17% | 51.1% | 235.9% | 38 |
| Oct 23, 2026 | 9.00 | $0.35 | $0.89 | -0.30 | 35 | 17% | 67.6% | 103.1% | 22 |
| Oct 23, 2026 | 9.50 | $0.21 | $0.74 | -0.35 | 35 | 17% | 58.0% | 81.2% | 2 |
| Oct 30, 2026 | 9.50 | $0.51 | $0.89 | -0.36 | 42 | 17% | 56.7% | 81.0% | 1 |
| Oct 2, 2026 | 9.50 | $0.10 | $0.24 | -0.28 | 14 | 17% | 66.0% | 65.9% | 21 |
| Sep 25, 2026 | 9.50 | $0.04 | $0.11 | -0.22 | 7 | 17% | 74.1% | 60.4% | 270 |
| Nov 20, 2026 | 9.00 | $0.48 | $0.86 | -0.30 | 63 | 17% | 61.2% | 55.0% | 0 |
| Oct 30, 2026 | 9.00 | $0.32 | $0.56 | -0.28 | 42 | 17% | 65.5% | 53.6% | 13 |
| Oct 9, 2026 | 9.00 | $0.19 | $0.27 | -0.23 | 21 | 17% | 73.9% | 51.2% | 266 |
| Oct 16, 2026 | 9.00 | $0.18 | $0.27 | -0.23 | 28 | 17% | 70.2% | 38.4% | 129 |
As of September 18, 2026
Run the Wheel on NVAX With Confidence
Find the best NVAX wheel strategy setups across strikes and expirations, plan ahead with at-strike values, and keep your covered calls and puts on track.
Start your 14-day free trial→